People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vitruvias Therapeutics, Inc. | — | Pharmaceuticals | Series A | $12.4M | $356.2M | 2013 |
Carl Leo Whatley, Jr. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Carl Leo Whatley, Jr. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bryce M Harvey | 1 | 1 |
| Jason D Wild | 1 | 1 |
| Roger D Graben | 1 | 1 |
| Michael D Altman | 1 | 1 |
| Edward D Schutter | 1 | 1 |
| Carl L Whatley | 1 | 1 |
| A Stuart Hendon | 1 | 1 |
| Charles T Smith | 1 | 1 |
| Thomas A Main | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.